美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

180 Life Sciences Corp Warrant

0.4300

0.0000

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：0.4300

開：0.4300

低：0.4300

收：0.4300

52周最高：0.6200

52周最低：0.0046

股本：- -

流通股本：- -

量比：0.15

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

180 Life Sciences Corp Warrant

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.180lifesciences.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

180 Life Sciences Corp.是一家根據特拉華州法律於2016年9月7日成立的公司。該公司是臨床階段的生物技術公司，致力於開發滿足炎症性疾病，纖維化和疼痛方面未滿足需求的新型藥物。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ATNFW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATNFW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNFW\",,,,,undefined,":{"symbol":"ATNFW","market":"US","secType":"STK","nameCN":"180 Life Sciences Corp Warrant","latestPrice":0.43,"timestamp":1772744400000,"preClose":0.43,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"盤前交易","change":0,"latestTime":"03-06 06:34:20 EST","open":0.43,"high":0.43,"low":0.43,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772807400000},"marketStatusCode":1,"symbolChange":{"newSymbol":"ETHZW","executeDate":"2025-08-18"},"adr":0,"exchange":"NASDAQ","adjPreClose":0.43,"volumeRatio":0.14779864850144905},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNFW\",,,,,undefined,":{"symbol":"ATNFW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.14779864850144905,"shares":0,"dividePrice":0,"high":0.43,"amplitude":0,"preClose":0.43,"low":0.43,"week52Low":0.0046,"pbRate":"--","week52High":0.62,"institutionHeld":0,"latestPrice":0.43,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATNFW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-18","symbol":"ATNFW","oldSymbol":"ATNFW","defaultRemindTime":1755523800000,"newSymbol":"ETHZW","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1755489600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATNFW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATNFW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.180lifesciences.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":46.7778},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0064},{"period":"6month","weight":0.0526},{"period":"1year","weight":0.1685},{"period":"ytd","weight":-0.0009}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"180 Life Sciences Corp.是一家根據特拉華州法律於2016年9月7日成立的公司。該公司是臨床階段的生物技術公司，致力於開發滿足炎症性疾病，纖維化和疼痛方面未滿足需求的新型藥物。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.115873},{"month":2,"riseRate":0.6,"avgChangeRate":0.278275},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.078861},{"month":4,"riseRate":0.4,"avgChangeRate":0.149346},{"month":5,"riseRate":0.4,"avgChangeRate":-0.07944},{"month":6,"riseRate":0.4,"avgChangeRate":-0.083285},{"month":7,"riseRate":0.2,"avgChangeRate":-0.002285},{"month":8,"riseRate":0.4,"avgChangeRate":7.214513},{"month":9,"riseRate":0.25,"avgChangeRate":-0.177193},{"month":10,"riseRate":0.75,"avgChangeRate":0.120623},{"month":11,"riseRate":0.5,"avgChangeRate":0.100347},{"month":12,"riseRate":0.2,"avgChangeRate":-0.082352}],"exchange":"NASDAQ","name":"180 Life Sciences Corp Warrant","nameEN":"180 Life Sciences Corp Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ATNFW\",market:\"US\",,,undefined,":null}}